Eventide Asset Management, LLC Decibel Therapeutics, Inc. Transaction History

Eventide Asset Management, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 16, 2021	SELL	$6.39 - $11.51 $1.28 Million - $2.3 Million	-200,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$10.56 - $19.9 $2.11 Million - $3.98 Million	200,000 New	200,000 $2.27 Million

Ticker DBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,964,500
Description
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.